Department of Endocrinology, K.S. Hegde Medical Academy, P.O. Nityanandanagar, Mangalore, Karnataka, 575018, India.
Department of Endocrinology, Amrita Institute of Medical Sciences, Cochin, Kerala, India.
Arch Osteoporos. 2021 Apr 14;16(1):69. doi: 10.1007/s11657-021-00931-8.
Using the FRAX® model for India, thresholds for osteoporosis evaluation and treatment without bone mineral density measurement were derived and were validated in a cohort of 300 patients. We suggest the use of this newer age and ethnic-specific FRAX®-derived thresholds for management of osteoporosis in India.
Our study aimed to formulate population-specific intervention thresholds for treatment of osteoporosis in India which can be used even without dual X-ray absorptiometry (DXA).
Using the FRAX® model for India, thresholds for different age groups for men and women were calculated without bone mineral density (BMD) measurement. The lower assessment threshold (LAT) was based on the 10-year probability of a major osteoporosis fracture (MOF) or hip fracture (HF) equivalent to patients without clinical risk factors. The intervention threshold (IT) was based on the 10-year probability equivalent to patients with fracture. The upper assessment threshold (UAT) was set at 1.2 times the IT. Probability-based thresholds for no intervention (LAT), treatment initiation (UAT) and BMD assessment (between LAT and UAT) were derived. The thresholds were validated in a cohort of 300 patients who were referred for BMD testing.
Graphs for age, gender, BMI and ethnic-specific LAT, IT and UAT for MOF and HF are derived. In the validation cohort, BMD testing to initiate/defer treatment was required in only 32.3% patients. The intervention thresholds derived without BMD testing were valid in 98.7% patients. Use of National Osteoporosis Foundation (NOF) guidelines would have resulted in overtreatment in 56/300 (18.6%) patients.
We suggest the use of this newer age and ethnic-specific FRAX®-derived thresholds for management of osteoporosis. Adopting these cut-offs will ensure that those requiring osteoporosis treatment will not be denied of it just because of lack of a DXA machine and will also help avoid overtreatment.
本研究旨在为印度制定骨质疏松症治疗的人群特异性干预阈值,即使没有双能 X 线吸收法(DXA)也可以使用。
使用印度 FRAX®模型,计算出不同年龄组男性和女性的无骨密度(BMD)测量的阈值。较低评估阈值(LAT)基于无临床危险因素的患者发生主要骨质疏松性骨折(MOF)或髋部骨折(HF)的 10 年概率。干预阈值(IT)基于骨折患者的 10 年概率。较高评估阈值(UAT)设定为 IT 的 1.2 倍。基于概率的不干预阈值(LAT)、治疗开始阈值(UAT)和 BMD 评估阈值(LAT 和 UAT 之间)。在 300 名因 BMD 检测而转诊的患者队列中验证了这些阈值。
得出了年龄、性别、BMI 和种族特异性 LAT、IT 和 UAT 与 MOF 和 HF 的图表。在验证队列中,只有 32.3%的患者需要进行 BMD 检测以开始/推迟治疗。未经 BMD 检测得出的干预阈值在 98.7%的患者中有效。如果使用国家骨质疏松基金会(NOF)指南,300 名患者中的 56 名(18.6%)将过度治疗。
我们建议使用这种新的年龄和种族特异性 FRAX®衍生的阈值来管理骨质疏松症。采用这些截止值将确保那些需要骨质疏松症治疗的人不会因为缺乏 DXA 机而无法接受治疗,也将有助于避免过度治疗。